Consolidated Portfolio Review Corp’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,473	Closed	-$1.86M	–	306
2024 Q1	$1.86M	Hold	14,473	–	–	0.49%	60
2023 Q4	$1.5M	Buy	+14,473	New	+$1.5M	0.34%	77